Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-01-27 | 2026-01-27 |
| Drug Identification Number | 02421712 | 02421712 |
| Brand name | DUTASTERIDE | DUTASTERIDE |
| Common or Proper name | DUTASTERIDE | DUTASTERIDE |
| Company Name | PRO DOC LIMITEE | PRO DOC LIMITEE |
| Ingredients | DUTASTERIDE | DUTASTERIDE |
| Strength(s) | 0.5MG | 0.5MG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 30 | 30 |
| Additional packaging sizes | ||
| ATC code | G04CB | G04CB |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2024-12-31 | 2024-12-31 |
| Remaining supply date | ||
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Replaced by DIN#02543990 | Replaced by DIN#02543990 |
| Health Canada comments |